✓ Medically Reviewed Monograph

Methotrexate

Also known as / Synonyms: MTX, Amethopterin, Antifolate DMARD

Anchor disease-modifying antirheumatic drug taken strictly ONCE PER WEEK with folic acid to control rheumatoid arthritis and psoriasis.

🩺
Reviewed by Dr. Lisa M., PharmD
Chief Clinical Editor · Updated November 19, 2026 · Editorial & Fact-Checking Policy
CDSCO & FDA Aligned
📋

Clinical Snapshot & Specifications

Generic Name: Methotrexate
Active Ingredient: Methotrexate Sodium
Dosage Form: Tablet
Available Strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg tablets; SC/IM injection
Prescription Status: Prescription only (Schedule H / verified)
Approved Routes:
Oral Subcutaneous Intramuscular
Popular Verified Brands:
Folitrax Trexall Mexate Imutrex (India)
Regulatory Standards: Approved by CDSCO; Schedule H prescription drug in India. Carries black-box warnings internationally regarding once-weekly dosing errors, hepatotoxicity, and teratogenicity.
🎯

Approved Indications & Medical Uses

  • Severe active rheumatoid arthritis (RA) in adults (anchor first-line DMARD).
  • Severe, recalcitrant, disabling psoriasis and psoriatic arthritis in adults unresponsive to other therapies.
  • Polyarticular juvenile idiopathic arthritis (pJIA) in children.
  • Maintenance therapy in acute lymphoblastic leukemia (ALL) and gestational choriocarcinoma (oncology regimens).
  • Severe refractory Crohn's disease (off-label).
🚫

Contraindications (Do Not Use If…)

  • Pregnancy and nursing mothers (BLACK BOX TERATOGEN & ABORTIFACIENT WARNING).
  • Severe hepatic impairment, alcoholic liver disease, or chronic cirrhosis.
  • Severe renal impairment (eGFR < 30 mL/min).
  • Pre-existing blood dyscrasias: bone marrow hypoplasia, leukopenia, thrombocytopenia, or significant anemia.
  • Active severe infections or immunodeficiency syndromes.
🛡️

Important Clinical Precautions & Warnings

  • STRICT ONCE-WEEKLY DOSING: for rheumatoid arthritis and psoriasis, methotrexate must be taken ONCE PER WEEK on the same designated day; accidental daily dosing leads to fatal bone marrow suppression and gastrointestinal hemorrhage; write the specific day of the week on prescription.
  • Mandatory Folic Acid supplementation: co-prescribe oral folic acid (1 mg/day or 5 mg once-weekly 24 hours after methotrexate) to reduce mucosal ulcers, nausea, and hematologic toxicity without diminishing antirheumatic efficacy.
  • Hepatotoxicity and cirrhosis: chronic use can cause hepatic fibrosis; monitor baseline and monthly liver function tests (LFTs); avoid alcohol entirely.
  • Bone marrow suppression: can cause severe, life-threatening pancytopenia and leukopenia; monitor complete blood counts (CBC) monthly.
  • Pneumonitis: acute or chronic non-productive cough, dyspnea, and fever may signify methotrexate-induced pulmonary toxicity; evaluate urgently and discontinue.
  • Nephrotoxicity: excreted primarily unchanged by kidneys; NSAIDs and dehydration significantly impair renal excretion, risking severe toxicity.

Special Populations (Paediatric & Geriatric Care)

Pediatric: Approved for juvenile idiopathic arthritis; weight-based weekly dosing. Geriatric: Elderly patients are at high risk of toxicity due to decreased renal clearance and low folate reserves; initiate with low starting doses (5 to 7.5 mg once weekly).

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Nausea, abdominal discomfort, stomatitis (mouth ulcers), fatigue, headache, dizziness, mild alopecia, and elevated transaminases.

🚨 Serious Side Effects — Seek Urgent Medical Care

Fatal bone marrow suppression (pancytopenia, agranulocytosis), acute liver cirrhosis and hepatic fibrosis, severe pneumonitis / pulmonary fibrosis, gastrointestinal perforation, and opportunistic infections.

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

  • NSAIDs and salicylates: compete for renal tubular secretion, significantly elevating methotrexate blood levels and triggering severe toxicity; use with extreme caution.
  • Trimethoprim-sulfamethoxazole (cotrimoxazole): additive antifolate activity; can precipitate fatal pancytopenia; strictly avoid combination.
  • Proton pump inhibitors (omeprazole): inhibit renal elimination of methotrexate.
  • Alcohol: substantially increases hepatotoxicity and cirrhosis risk; strictly avoid.
🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

EXTREMELY TERATOGENIC AND ABORTIFACIENT (FDA Category X). Causes fetal death, craniofacial abnormalities, and skeletal defects. Female patients must use effective contraception during and for at least 6 months after therapy; male patients must use contraception for at least 3 months after therapy.

Lactation & Breastfeeding:

Contraindicated in nursing mothers due to serious adverse effects on infant hematopoiesis and growth.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store tablets at 20°C to 25°C (68°F to 77°F). Protect from light and moisture.

⏱️ Missed Dose Protocol:

If missed on the designated weekly day, take within 2 days; otherwise skip and resume on the next scheduled weekly day. Never take extra tablets to compensate.

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.